# The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

> **NCT04112069** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 20 (actual)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DEVICE:** iLet Bionic Pancreas insulin-only configuration with Humalog or Novolog
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT04112069
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-09
- **Primary completion:** 2018-11-19
- **Final completion:** 2018-11-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04112069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04112069, "The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04112069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*